These prostate cancer-specific gene rearrangements may be explained by the fact that androgen treatment in AR-positive prostate cancer cell lines induced proximity between TMPRSS2 and ERG [58]. This evidence concerns the gene TMPRSS2 and Familial prostate cancer.